Medicover AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,088.00
229.00
269.00
205.00
1,448.00
390.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-56.00
-205.00
-165.00
-421.00
-415.00
-7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3,176.00
2,379.00
1,865.00
1,484.00
2,009.00
1,483.00
Cash Flow from Investing Activities
-3,701.00
-2,558.00
-1,473.00
-2,058.00
-3,410.00
-1,350.00
Cash Flow from Financing Activities
699.00
397.00
-259.00
159.00
1,880.00
30.00
Net Cash Inflow / Outflow
138.00
217.00
119.00
-441.00
357.00
124.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-36.00
-2.00
-12.00
-27.00
-121.00
-38.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medicover AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
1088.0373160104
772
316.00
40.94%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-56.4495453881288
29
-85.00
-294.65%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3176.67049537117
1392
1,784.00
128.21%
Cash Flow from Investing Activities
-3701.31921133143
-497
-3,204.00
-644.73%
Cash Flow from Financing Activities
699.531621280342
-305
1,004.00
329.35%
Net Cash Inflow / Outflow
138.356728892473
482
-344.00
-71.30%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-36.5261764276128
-108
72.00
66.18%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 33.48% vs 27.61% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
3,176.67
2,379.92
33.48%






